“These results provide the basis for the administration of PF-114 in treatment-resistant patients with Ph+ leukemia. The favourable efficacy and good side effect profile now need to be further tested on patients in clinical phase I studies," explained Dr. Ruthardt. "PF-114 would not have reached t
“These results provide the basis for the administration of PF-114 in treatment-resistant patients with Ph+ leukemia. The favourable efficacy and good side effect profile now need to be further tested on patients in clinical phase I studies," explained Dr. Ruthardt. "PF-114 would not have reached t
このブックマークにはスターがありません。
最初のスターをつけてみよう！
New substance overcomes treatment-resistance in leukemia -- ScienceDaily
1 人がブックマーク・1 件のコメント
＼ コメントが サクサク読める アプリです ／